Discussion highlights additional dermatologic disorders with ocular involvement, suggesting a need for interdisciplinary collaboration.
We appreciate Dr. Anju George's thoughtful Letter to the Editor, 'Expanding the Interface: Overlooked Dermatologic Disorders With Ocular Involvement', as a comment on our article, 'The Interconnected World of Dermatology and Ophthalmology', published in JEADV Clinical Practice [1]. We are delighted to know that our manuscript made a stir and led to start of discussion in this sector. We also extend our heartfelt congratulations to JEACP and its esteemed editorial board for their impactful role in amplifying this discussion. Dr. George's letter further enriches the review by highlighting additional dermatologic conditions along with ocular manifestations that were not detailed in our review, including blistering diseases, infectious disease(s), congenital ichthyoses, porphyrias, Behçet's disease, and various genodermatoses. Her inclusion of two comprehensive tables further summarises the contribution, providing an organized overview of the disorders. Our original review aimed to furnish prevalent conditions bridging dermatology and ophthalmology, emphasizing those with significant multisystem impact to advocate for interdisciplinary collaboration. Due to word constraints (limited to 4000 words) and the need to prioritize disorders, we had to omit several disorders which has impact on other system of the body. Dr. George correctly identifies these omissions and offers a valuable extension. We harmonize with this emphasis on the diagnostic and therapeutic implications of these conditions. However, we note that some conditions, like herpes zoster ophthalmicus, were excluded from our review due to their well-established ophthalmic focus in the pre-existing literature, though we acknowledge their relevance to the skin-eye interface as suggested. The exclusion of chronic infections like syphilis and leprosy, as mentioned, was intentional, given their diverse multisystem nature and the review's focus on primary dermato-ophthalmologic entities. Nevertheless, the opinion about early recognition preventing irreversible damage is well-taken and resonates with our article's core message. Dr. George's contribution prompts reflection on the balance between comprehensiveness and focus in review articles but considering the word limit the manuscript often needs pruning. We welcome her additions as a complementary resource, enhancing clinical awareness. We propose that future reviews could explore these conditions' prevalence and management thoroughly. This collaborative dialogue illustrates the interdisciplinary slant we advocated, and we thank Dr. George for advancing this important discussion. G.R., S.G., K.D. and G.P. wrote the initial draft of manuscript. G.R., S.G., K.D., G.P. and P.P. revised and prepared the final version of the manuscript. All authors have read and approved the final manuscript and agree to take full responsibility for the integrity and accuracy of the work. The authors have nothing to report. The authors have nothing to report. The authors declare no conflicts of interest. Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.
No takes yet. Share an insight, caveat, or question.
Pudasaini et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: